The purpose of this study is to develop a pilot screening protocol, comparing cardiac point-of-care ultrasound (POCUS), electrocardiogram (EKG), serum biomarkers (N-terminal pro b-type natriuretic peptide (NT-proBNP), high sensitivity troponin (hsTn)) with formal transthoracic echocardiogram (TTE) in pregnant women with methamphetamine use.
18 years or older > 20 weeks gestation admitted to the hospital
Active patient-defined regular methamphetamine use for at least 1 year and any use within the last month
Able to understand and provide informed consent
Able to understand English
Prescribed stimulants
Echocardiogram or EKG previously performed during current pregnancy
Previous diagnosis of congestive heart dysfunction
Previous diagnosis of pulmonary hypertension